NewsRoom Articles - Page 253 of 607

MondayAug 09, 2021 1:06 pm

InMed Pharmaceuticals Inc. (NASDAQ: INM) and Its Quest to Build an Industry-Leading, Rare Cannabinoid Enterprise

InMed announced a non-binding letter of intent to acquire BayMedica Inc. The move is designed to grow InMed’s market presence and strengthen its operations The two companies have had a reciprocal research collaboration that dates back to November 2020 InMed looks to capitalize on the growing cannabinoid industry that is projected to grow at a CAGR of 21.2% from 2021 to 2028 InMed Pharmaceuticals (NASDAQ: INM) is a clinical-stage company committed to developing cannabinoid-based pharmaceutical drug candidates. It also manufactures technologies for pharmaceutical-grade rare cannabinoids. It is known for creating a pipeline of cannabinoid-based pharmaceutical drug candidates to treat various…

MondayAug 09, 2021 4:20 am

420 with CNW — Patients with High-Grade Gliomas Register Improved Quality of Life after Using Medical Marijuana

The past few decades have seen cannabis progress from an intensely policed drug with no perceived medical applications to a “miracle drug” with a plethora of health benefits. Anecdotal reports and preliminary studies have found it to be effective against, among other things, chronic pain, anxiety insomnia, nausea and vomiting, which are incidentally the symptoms often endured by individuals suffering from cancer who are undergoing chemotherapy. Thanks to restrictive cannabis policies, few researchers have been able to conclusively study how cannabis affects the quality of life of cancer patients. However, a recent study published in “Frontiers in Oncology” sought to…

FridayAug 06, 2021 4:20 pm

420 with CNW — Why Investors Interested in Cannabis Should Expect a Big Stock Surge

At the moment, more than 100 million residents in the United States live in a state that has legalized recreational cannabis, with a whopping 95% living in a state with a legal medical cannabis system in place. Cannabis multistate operators are readying themselves for the next huge stock increase, which is expected to happen even without a change in federal legislations. Marijuana is fast closing the revenue gap, especially with the emergence of profitability, after the huge infrastructure spending that began in 2018 and 2019. Trading indexes show favorable valuations throughout this season, despite the imminent federal legislative gridlock. Marijuana…

FridayAug 06, 2021 9:30 am

First Results from Lexaria Bioscience Corp. (NASDAQ: LEXX) Study Show Marked Gains in Blood Pressure Reduction over Generic CBD Controls

Drug delivery platform developer Lexaria Bioscience has developed its patented DehydraTECH(TM) as a means of transforming pharmaceuticals that increases their bioavailability and speed of efficacy Ongoing testing of DehydraTECH in combination with cannabidiol (“CBD”) is analyzing DehydraTECH’s responsiveness to hypertension conditions that are targeted in heart disease and stroke therapies Partial results from the company’s first study indicate Lexaria’s DehydraTECH platform, when processed with CBD, reduces blood pressure and does so much more rapidly when compared with the generic CBD controls The complete results of the study will be produced as sample and data analyses work are completed Lexaria is…

FridayAug 06, 2021 9:00 am

RYAH Group Inc. (CSE: RYAH) Sees Important Trends in Sports Medicine and Plant-Therapy

As U.S. research restrictions are lifted there is a rising interest in the use of plant-therapy in sports medicine Cannabis in sports medicine took center stage at the Tokyo Olympics American athletes are turning more and more to cannabis as a pain reliever, alternative to opioids, and part of an overall sports recovery plan RYAH Group (CSE: RYAH) (formerly RYAH Medtech), the leader in dose-control technology for plant-based medicine, works with researchers to provide a full turnkey solution for clinical studies from start to finish. RYAH Group's dose-control devices standardize the dosing protocol, QR products ensure compliance, and mobile apps…

FridayAug 06, 2021 4:20 am

420 with CNW — California Senator Asks Feds to Clarify Medical Cannabis Use Within Hospitals

The state legal cannabis industry can be a frustrating and confusing space. Despite the fact that more than 30 states have legalized medical marijuana, federal law still considers cannabis a Schedule I controlled substance with no medical applications. So while on one end nearly 5.5 million patients are using medical cannabis to alleviate a variety of medical issues, the federal government outlaws the controversial drug and requires federal agencies and institutions that rely on federal funding to follow its marijuana policies. This has been a significant issue for the past few years, with businesses and individuals finding themselves penalized by…

ThursdayAug 05, 2021 4:20 pm

420 with CNW — Study Finds That Patients with Epilepsy Who Use CBD Have Higher Quality of Life

A recent study has found that patients with epilepsy who use CBD products experienced better sleep and a higher quality of life in comparison with those who didn’t take CBD. The study, which was carried out in partnership with scientists at the Johns Hopkins University School of Medicine, was published in the “Epilepsy & Behavior” journal. The study discovered that epilepsy patients who used cannabinoid products also experienced less psychiatric symptoms, including anxiety, used fewer prescription medications generally and tolerated medications prescribed for epilepsy better. They also reported decreased healthcare use in comparison with patients in the control group. The…

ThursdayAug 05, 2021 1:17 pm

Grapefruit USA Inc. (GPFT) Signs Agreement with Leading Canadian Cannabis Manufacturer to Offer Game-Changing THC/CBD Cream

GPFT forms strategic alliance with 6PAK Solutions Inc Company working to achieve goal of launching Hourglass in Canada in the third quarter of 2021 Grapefruit’s patented Hourglass delivery cream system has fundamentally changed the way humans absorb cannabinoids In the United States, Grapefruit USA (OTCQB: GPFT) provides consumers with one of the most effective cannabis topical creams on the market. Now, through its partnership with 6PAK Solutions Inc., Grapefruit can offer its patented Hourglass(TM) Time Release THC+CBD Delivery Topical Relief Cream in Canada too (https://cnw.fm/qeAd5). “We are very encouraged by 6PAK’s decision to form an alliance with Grapefruit to take…

ThursdayAug 05, 2021 4:20 am

420 with CNW — Study Finds That Genetics Cause Hemp Plants to Produce More THC, Not Environmental Stresses

The use of CBD in various applications, including the treatment of depression, anxiety and pain and easing symptoms associated with cancer, has made cultivating hemp for CBD a booming industry. However, when hemp contains THC that exceeds the legal limit, the crop can test “hot.” THC is the psychoactive ingredient found in marijuana that gets a person high. Federal and state regulations classify hemp as containing no more than 0.3% THC, meaning that growers can lose their entire crop if the plants exceed the stipulated THC level. Various articles and websites have claimed that biological or environmental stresses, like crop…

WednesdayAug 04, 2021 4:20 pm

420 with CNW — Researchers Opt for Creative Ways to Study Federally Prohibited Marijuana

Since its inception, America's cannabis industry has been in a precarious position. Although 37 states have legalized medical marijuana, the federal government still classifies marijuana as a Schedule I controlled substance. This has essentially shackled the state-legal cannabis industry and has been especially detrimental to cannabis research. While cannabis is said to be effective against a wide range of medical issues, there isn't a lot of scientific data backing up these claims. Since cannabis companies aren't allowed to test their products on people before releasing them to the market, they essentially rely on customer feedback to tweak and improve products.…

News and publishing service for cannabis related companies

Contact us: 512.354.7000